Departments of1Radiology and.
2Neurosurgery, University of Texas Southwestern, Dallas, Texas.
J Neurosurg. 2019 Mar 1;130(3):999-1005. doi: 10.3171/2017.8.JNS17459. Epub 2019 Mar 2.
The role of venous sinus stenting (VSS) for idiopathic intracranial hypertension (IIH) is not well understood. The aim of this systematic review is to attempt to identify subsets of patients with IIH who will benefit from VSS based on the pressure gradients of their venous sinus stenosis.
MEDLINE/PubMed was searched for studies reporting venous pressure gradients across the stenotic segment of the venous sinus, pre- and post-stent pressure gradients, and clinical outcomes after VSS. Findings are reported according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
From 32 eligible studies, a total of 186 patients were included in the analysis. Patients who had favorable outcomes had higher mean pressure gradients (22.8 ± 11.5 mm Hg vs 17.4 ± 8.0 mm Hg, p = 0.033) and higher changes in pressure gradients after stent placement (19.4 ± 10.0 mm Hg vs 12.0 ± 6.0 mm Hg, p = 0.006) compared with those with unfavorable outcomes. The post-stent pressure gradients between the 2 groups were not significantly different (2.8 ± 4.0 mm Hg vs 2.7 ± 2.0 mm Hg, p = 0.934). In a multivariate stepwise logistic regression controlling for age, sex, body mass index, CSF opening pressure, pre-stent pressure gradient, and post-stent pressure gradient, the change in pressure gradient with stent placement was found to be an independent predictor of favorable outcome (p = 0.028). Using a pressure gradient of 21 as a cutoff, 81/86 (94.2%) of patients with a gradient > 21 achieved favorable outcomes, compared with 82/100 (82.0%) of patients with a gradient ≤ 21 (p = 0.022).
There appears to be a relationship between the pressure gradient of venous sinus stenosis and the success of VSS in IIH. A randomized controlled trial would help elucidate this relationship and potentially guide patient selection.
静脉窦支架置入术(VSS)在特发性颅内高压(IIH)中的作用尚不清楚。本系统评价的目的是试图根据静脉窦狭窄段的压力梯度,确定 IIH 患者中哪些亚组将从 VSS 中获益。
检索 MEDLINE/PubMed 以获取报告静脉窦狭窄段跨狭窄段静脉压力梯度、支架置入前后压力梯度和 VSS 后临床结局的研究。根据 PRISMA(系统评价和荟萃分析的首选报告项目)指南报告结果。
从 32 项合格研究中,共有 186 名患者纳入分析。具有良好结局的患者平均压力梯度更高(22.8 ± 11.5 mm Hg 比 17.4 ± 8.0 mm Hg,p = 0.033),支架置入后压力梯度变化更大(19.4 ± 10.0 mm Hg 比 12.0 ± 6.0 mm Hg,p = 0.006),与不良结局患者相比。两组支架置入后的压力梯度无显著差异(2.8 ± 4.0 mm Hg 比 2.7 ± 2.0 mm Hg,p = 0.934)。在多变量逐步逻辑回归中,控制年龄、性别、体重指数、CSF 开放压、支架置入前压力梯度和支架置入后压力梯度,发现支架置入后压力梯度变化是良好结局的独立预测因子(p = 0.028)。使用 21 作为截止值,压力梯度>21 的 81/86(94.2%)例患者获得良好结局,而压力梯度≤21 的 82/100(82.0%)例患者获得良好结局(p = 0.022)。
静脉窦狭窄的压力梯度与 IIH 中 VSS 的成功似乎存在关系。随机对照试验将有助于阐明这种关系,并可能为患者选择提供指导。